Safety And Immunogenicity Of An Rad26 And Rad5 Vector Based Heterologous Prime Boost Covid 19 Vaccine In Two Formulations Two Open Non Randomised Phase 1 2 Studies From Russia The Lancet
www.thelancet.com
Observational Study Of Hydroxychloroquine In Hospitalized Patients With Covid 19 Nejm
www.nejm.org
Coronavirus Nyc Setting Up Quarantine Checkpoints
www.cnbc.com